These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37328648)

  • 1. Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function.
    Zhu XX; Wang X; Jiao SY; Liu Y; Shi L; Xu Q; Wang JJ; Chen YE; Zhang Q; Song YT; Wei M; Yu BQ; Fielitz J; Gonzalez FJ; Du J; Qu AJ
    Acta Pharmacol Sin; 2023 Nov; 44(11):2184-2200. PubMed ID: 37328648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling.
    Wang X; Zhu XX; Jiao SY; Qi D; Yu BQ; Xie GM; Liu Y; Song YT; Xu Q; Xu QB; Gonzalez FJ; Du J; Wang XM; Qu AJ
    Acta Pharmacol Sin; 2022 May; 43(5):1231-1242. PubMed ID: 34376812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhematopoietic Peroxisome Proliferator-Activated Receptor-α Protects Against Cardiac Injury and Enhances Survival in Experimental Polymicrobial Sepsis.
    Standage SW; Waworuntu RL; Delaney MA; Maskal SM; Bennion BG; Duffield JS; Parks WC; Liles WC; McGuire JK
    Crit Care Med; 2016 Aug; 44(8):e594-603. PubMed ID: 26757163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.
    Standage SW; Bennion BG; Knowles TO; Ledee DR; Portman MA; McGuire JK; Liles WC; Olson AK
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H239-H249. PubMed ID: 27881386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
    Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
    Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.
    Drosatos K; Drosatos-Tampakaki Z; Khan R; Homma S; Schulze PC; Zannis VI; Goldberg IJ
    J Biol Chem; 2011 Oct; 286(42):36331-9. PubMed ID: 21873422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice
    Cai Y; Liu H; Song E; Wang L; Xu J; He Y; Zhang D; Zhang L; Cheng KK; Jin L; Wu M; Liu S; Qi D; Zhang L; Lopaschuk GD; Wang S; Xu A; Xia Z
    Theranostics; 2021; 11(10):4710-4727. PubMed ID: 33754023
    [No Abstract]   [Full Text] [Related]  

  • 9. Overexpression of Peroxisome Proliferator-Activated Receptor γ Coactivator 1-α Protects Cardiomyocytes from Lipopolysaccharide-Induced Mitochondrial Damage and Apoptosis.
    Zhang T; Liu CF; Zhang TN; Wen R; Song WL
    Inflammation; 2020 Oct; 43(5):1806-1820. PubMed ID: 32529514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro.
    Yang Y; Zhang H; Li X; Yang T; Jiang Q
    Int J Clin Exp Pathol; 2015; 8(10):12216-24. PubMed ID: 26722406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.
    Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosmarinic acid protects against lipopolysaccharide-induced cardiac dysfunction via activating Sirt1/PGC-1α pathway to alleviate mitochondrial impairment.
    Peng K; Yang F; Qiu C; Yang Y; Lan C
    Clin Exp Pharmacol Physiol; 2023 Mar; 50(3):218-227. PubMed ID: 36350269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function.
    Drosatos K; Pollak NM; Pol CJ; Ntziachristos P; Willecke F; Valenti MC; Trent CM; Hu Y; Guo S; Aifantis I; Goldberg IJ
    Circ Res; 2016 Jan; 118(2):241-53. PubMed ID: 26574507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway.
    Zhang Z; Yao T; Zhao N; Liu H; Cheng H; Gonzalez FJ; Wang H; Wang G; Qu A; Wang Y
    Int J Biol Sci; 2022; 18(6):2317-2328. PubMed ID: 35414769
    [No Abstract]   [Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice.
    Drosatos K; Khan RS; Trent CM; Jiang H; Son NH; Blaner WS; Homma S; Schulze PC; Goldberg IJ
    Circ Heart Fail; 2013 May; 6(3):550-62. PubMed ID: 23572494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
    Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
    Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
    Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
    Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation.
    Kienesberger PC; Pulinilkunnil T; Nagendran J; Young ME; Bogner-Strauss JG; Hackl H; Khadour R; Heydari E; Haemmerle G; Zechner R; Kershaw EE; Dyck JR
    Cardiovasc Res; 2013 Aug; 99(3):442-51. PubMed ID: 23708736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.
    Xie G; Yin S; Zhang Z; Qi D; Wang X; Kim D; Yagai T; Brocker CN; Wang Y; Gonzalez FJ; Wang H; Qu A
    Am J Pathol; 2019 Feb; 189(2):272-282. PubMed ID: 30448405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.